Eli Lilly announced positive Phase 1b Heart-2 study results for VERVE-102, an experimental heart treatment. The trial showed the drug was safe and worked as expected in patients.
Phase 1b Heart-2 Trial Study type
Positive Results Status
Eli Lilly announced positive Phase 1b Heart-2 study results for VERVE-102, an experimental heart treatment. The trial showed the drug was safe and worked as expected in patients.